Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Jesse Huang, Mohsen Khademi, Lars Fugger, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 23, pp. 12952-12960
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Current and Future Biomarkers in Multiple Sclerosis
Jennifer Yang, Maysa Hamade, Qi Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5877-5877
Open Access | Times Cited: 91
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
Yoshiaki Yasumizu, Daiki Takeuchi, Reo Morimoto, et al.
Cell Genomics (2024) Vol. 4, Iss. 2, pp. 100473-100473
Open Access | Times Cited: 19
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
Lorenzo Gaetani, Federico Paolini Paoletti, G. Bellomo, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 1023-1037
Closed Access | Times Cited: 72
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Allan I. Levey, Deqiang Qiu, Liping Zhao, et al.
Brain (2021) Vol. 145, Iss. 6, pp. 1924-1938
Open Access | Times Cited: 66
Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4610-4610
Open Access | Times Cited: 49
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Julia Åkesson, Sara Hojjati, Sandra Hellberg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology
Corneliu Toader, Nicolaie Dobrin, Felix-Mircea Brehar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16119-16119
Open Access | Times Cited: 26
Emerging imaging and liquid biomarkers in multiple sclerosis
Alexander J. Gill, Emily Schorr, Sachin P. Gadani, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 24
Cinnamomum verum extract inhibits NOX2/ROS and PKCδ/JNK/AP-1/NF-κB pathway-mediated inflammatory response in PMA-stimulated THP-1 monocytes
Na‐Yeon Kim, Seon-Hwa Kim, Hyo‐Min Park, et al.
Phytomedicine (2023) Vol. 112, pp. 154685-154685
Open Access | Times Cited: 23
Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
Wojciech Pasławski, Shervin Khosousi, Ellen Hertz, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Methods and clinical biomarker discovery for targeted proteomics using Olink technology
Han Wang, Tian Zhao, Jingjing Zeng, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2024) Vol. 18, Iss. 5
Closed Access | Times Cited: 8
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis
Johanna Oechtering, Sabine Schädelin, Kerstin Stein, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 2
Closed Access | Times Cited: 1
Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
Nicholas Cullen, Anders Mälarstig, Erik Stomrud, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Photobiomodulation for the treatment of neuroinflammation: A systematic review of controlled laboratory animal studies
Fabrízio dos Santos Cardoso, Farzad Salehpour, Norberto Cysne Coimbra, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 33
Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders
Camilla Christina Pedersen, Anastasia Ushakova, Ragnhild Skogseth, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 4
Open Access | Times Cited: 21
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
Kiersten Campbell, Niamh X. Cawley, Rachel Luke, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
Eleftheria Kodosaki, William J. Watkins, Sam Loveless, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype
Phillip S. Gross, Violeta Durán Laforet, Zeeba Manavi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Intrathecal Inflammation in Progressive Multiple Sclerosis
Salvatore Monaco, Richard Nicholas, Richard Reynolds, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8217-8217
Open Access | Times Cited: 46
Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches
Ameneh Jafari, Amirhesam Babajani, Mostafa Rezaei‐Tavirani
Biomarker Insights (2021) Vol. 16
Open Access | Times Cited: 35
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
Dániel Sandi, Zsófia Kokas, Tamás Biernacki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5162-5162
Open Access | Times Cited: 27
Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity
Doryssa Hermans, Evelien Houben, Paulien Baeten, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 2, pp. 259-281
Closed Access | Times Cited: 22
Sex Differences in the Inflammatory Profile in the Brain of Young and Aged Mice
Brianna Cyr, Juan Pablo de Rivero Vaccari
Cells (2023) Vol. 12, Iss. 10, pp. 1372-1372
Open Access | Times Cited: 14
Artificial Intelligence and Multiple Sclerosis
Moein Amin, Eloy Martínez‐Heras, Daniel Ontaneda, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 8, pp. 233-243
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top